VIA

Virtus Investment Advisers Portfolio holdings

AUM $368M
1-Year Est. Return 26.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+26.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$349M
AUM Growth
+$53.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
478
New
Increased
Reduced
Closed

Top Buys

1
+$2.36M
2
+$1.99M
3
+$1.97M
4
IDXX icon
Idexx Laboratories
IDXX
+$1.96M
5
TKO icon
TKO Group
TKO
+$1.96M

Top Sells

1
+$1.85M
2
+$1.62M
3
+$1.62M
4
CBRE icon
CBRE Group
CBRE
+$1.61M
5
NU icon
Nu Holdings
NU
+$1.58M

Sector Composition

1 Financials 33.25%
2 Healthcare 17.27%
3 Technology 14.61%
4 Industrials 8.9%
5 Consumer Discretionary 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OVV icon
351
Ovintiv
OVV
$14.3B
$169K 0.05%
4,182
+48
REXR icon
352
Rexford Industrial Realty
REXR
$8.69B
$168K 0.05%
4,092
-602
BRY
353
DELISTED
Berry Corp
BRY
$168K 0.05%
44,499
-7,489
IVT icon
354
InvenTrust Properties
IVT
$2.42B
$168K 0.05%
5,865
-295
EOG icon
355
EOG Resources
EOG
$66.6B
$168K 0.05%
1,496
+127
CRC icon
356
California Resources
CRC
$5.26B
$168K 0.05%
3,154
-527
LXP icon
357
LXP Industrial Trust
LXP
$2.93B
$167K 0.05%
3,733
-193
TRNO icon
358
Terreno Realty
TRNO
$6.85B
$167K 0.05%
2,935
-35
PTEN icon
359
Patterson-UTI
PTEN
$3.23B
$166K 0.05%
32,033
+5,016
ARCT icon
360
Arcturus Therapeutics
ARCT
$234M
$166K 0.05%
9,002
+1,563
RCUS icon
361
Arcus Biosciences
RCUS
$2.52B
$165K 0.05%
12,169
+2,112
PHVS icon
362
Pharvaris
PHVS
$1.84B
$165K 0.05%
6,604
+1,147
SNDX icon
363
Syndax Pharmaceuticals
SNDX
$1.89B
$164K 0.05%
10,664
+1,851
ERAS icon
364
Erasca
ERAS
$4.23B
$162K 0.05%
74,371
+12,912
SANA icon
365
Sana Biotechnology
SANA
$1.12B
$159K 0.05%
44,798
+7,777
ARQT icon
366
Arcutis Biotherapeutics
ARQT
$3.3B
$159K 0.05%
8,429
+1,464
BEAM icon
367
Beam Therapeutics
BEAM
$2.89B
$158K 0.05%
6,524
+1,132
IMTX icon
368
Immatics
IMTX
$1.39B
$158K 0.05%
18,532
+3,217
VRDN icon
369
Viridian Therapeutics
VRDN
$2.8B
$157K 0.04%
7,262
+1,261
BCAX
370
Bicara Therapeutics
BCAX
$919M
$155K 0.04%
9,835
+1,708
RNAM
371
Avidity Biosciences
RNAM
$11.2B
$154K 0.04%
3,540
+614
TYRA icon
372
Tyra Biosciences
TYRA
$1.78B
$154K 0.04%
11,015
+1,912
NAMS icon
373
NewAmsterdam Pharma
NAMS
$4.08B
$154K 0.04%
5,411
+940
KURA icon
374
Kura Oncology
KURA
$760M
$151K 0.04%
17,085
+2,966
ANAB icon
375
AnaptysBio
ANAB
$1.52B
$149K 0.04%
4,860
+843
13 14
15
16 17